WELL Health Technologies Corp. (TSE:WELL) Receives C$7.39 Consensus PT from Brokerages

WELL Health Technologies Corp. (TSE:WELL) has received a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is C$7.39.

Several research analysts recently weighed in on the company. Pi Financial raised their target price on WELL Health Technologies from C$8.25 to C$8.50 in a research note on Wednesday, January 31st. Royal Bank of Canada set a C$5.50 price target on shares of WELL Health Technologies and gave the stock an “outperform” rating in a research report on Tuesday, February 6th. Finally, CIBC cut WELL Health Technologies from an “outperform” rating to a “neutral” rating and dropped their price target for the company from C$5.50 to C$4.75 in a report on Monday, January 22nd.

WELL Health Technologies Stock Down 0.3 %

WELL opened at C$3.52 on Friday. The company has a debt-to-equity ratio of 50.38, a current ratio of 1.15 and a quick ratio of 1.02. WELL Health Technologies has a 12 month low of C$3.41 and a 12 month high of C$5.94. The stock’s 50 day moving average price is C$3.82 and its 200 day moving average price is C$3.87. The stock has a market cap of C$864.62 million, a P/E ratio of -185.00, a P/E/G ratio of -1.93 and a beta of 1.27.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.